These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32999164)

  • 1. Ginsenoside Rd Inhibits Glioblastoma Cell Proliferation by Up-Regulating the Expression of miR-144-5p.
    Liu GM; Lu TC; Sun ML; Jia WY; Ji X; Luo YG
    Biol Pharm Bull; 2020; 43(10):1534-1541. PubMed ID: 32999164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated Smad2 expression.
    Wang P; Du X; Xiong M; Cui J; Yang Q; Wang W; Chen Y; Zhang T
    Sci Rep; 2016 Sep; 6():33709. PubMed ID: 27641158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside 20(S)-Rg3 suppresses cell viability in esophageal squamous cell carcinoma via modulating miR-324-5p-targeted PSME3.
    Jiang M; Zhu Y; Yu H
    Hum Exp Toxicol; 2021 Nov; 40(11):1974-1984. PubMed ID: 34002647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis.
    Chang L; Wang D; Kan S; Hao M; Liu H; Yang Z; Xia Q; Liu W
    J Appl Oral Sci; 2022; 30():e20220144. PubMed ID: 36074434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 Prevents Oncogenic Long Noncoding RNA ATXN8OS from Inhibiting Tumor-Suppressive microRNA-424-5p in Breast Cancer Cells.
    Kim H; Ji HW; Kim HW; Yun SH; Park JE; Kim SJ
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.
    Wang X; Sun S; Tong X; Ma Q; Di H; Fu T; Sun Z; Cai Y; Fan W; Wu Q; Li Y; Wang Q; Wang J
    Brain Res; 2017 Dec; 1676():69-76. PubMed ID: 28842123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
    Xu H; Hu Y; Qiu W
    Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p.
    Zhang J; Furuta T; Sabit H; Tamai S; Jiapaer S; Dong Y; Kinoshita M; Uchida Y; Ohtsuki S; Terasaki T; Zhao S; Nakada M
    Cancer Sci; 2020 Jul; 111(7):2413-2422. PubMed ID: 32324311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-6858 plays a key role in the process of melatonin inhibition of the malignant biological behavior of glioma.
    Wang C; Zhao Z; Qi Q; Wang J; Kong Y; Feng Z; Chen A; Li W; Zhang Q; Wang J; Huang B; Li X
    J Clin Neurosci; 2021 May; 87():137-146. PubMed ID: 33863521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
    Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of ginsenoside Rd in gastric cancer via up-regulation of Caspase-3 and Caspase-9.
    Tian YZ; Liu YP; Tian SC; Ge SY; Wu YJ; Zhang BL
    Pharmazie; 2020 Apr; 75(4):147-150. PubMed ID: 32295691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment.
    Huang C; Ma L; Duan F; Li R; Zhang Y; Wang Y; Luo M; He Z; Luo Z
    Bioengineered; 2021 Dec; 12(1):8020-8030. PubMed ID: 34726120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.
    Zhang G; Hu J; Li A; Zhang H; Guo Z; Li X; You Z; Wang Y; Jing Z
    Phytomedicine; 2024 Jul; 129():155631. PubMed ID: 38640858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.
    Chen Y; Shang H; Zhang S; Zhang X
    J Cell Biochem; 2018 Aug; 119(8):6527-6534. PubMed ID: 29377269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis.
    Chen WL; Jiang L; Wang JS; Liao CX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10874-10885. PubMed ID: 31858556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.